![]() |
市場調查報告書
商品編碼
1399747
家庭護理制氧機市場 - 按產品(攜帶式製氧機、固客製化氧機)、按技術(連續流、脈衝流) - 全球預測,2023-2032 年Homecare Oxygen Concentrators Market - By Product (Portable Oxygen Concentrators, Fixed Oxygen Concentrators), By Technology (Continuous Flow, Pulse Flow) - Global Forecast, 2023-2032 |
在呼吸系統疾病盛行率上升、轉向家庭醫療保健以及醫療技術進步的推動下,全球家庭護理制氧機市場預計在 2023 年至 2032 年期間CAGR為 6%。
根據非傳染性疾病聯盟 2022 年發布的報告,全球有近 5.5 億成年人患有慢性呼吸道疾病,數字持續上升。隨著越來越多的人被診斷出患有慢性阻塞性肺病(COPD)和氣喘等慢性呼吸系統疾病,對居家氧氣治療的需求不斷增加。
此外,根據Visual Capitalist公佈的資料,2022年,全球65歲及以上人口達到7.71億,佔全球人口的近10%,預計到2050年將激增至16%。全球人口老化、生活方式疾病和呼吸系統疾病的易感性增加,促進了產品的採用。
家用制氧機產業根據產品、技術和地區進行分類。
由於效率、降噪和方便用戶使用功能方面的創新,固客製化氧機領域預計將在預測期內為行業成長做出重大貢獻。該產品不僅確保持續可靠的氧氣供應,還提高了患者的舒適度和可及性。此外,現代固定式氧氣機配備了更長的電池壽命,增強了設備的可用性,使患者在日常活動中具有更大的靈活性,而無需頻繁充電。
脈衝流技術領域預計到 2032 年將實現穩定成長,因為它透過脈衝或爆發式輸送氧氣來運行,與患者的呼吸模式保持一致。這種創新方法可確保在需要時精確供氧,從而節省資源並提高治療的整體效果。此外,與連續流設備相比,脈衝流設備通常設計得更緊湊、更輕,這最終增強了患者的活動能力,使個人能夠更輕鬆地從事日常活動。
在該地區龐大的人口和不斷發展的醫療基礎設施的推動下,亞太地區家庭護理制氧機行業將在研究期間經歷強勁成長。在中國和印度等國家,人們越來越關注家庭醫療保健解決方案。這一因素,加上支持家庭醫療保健解決方案和醫療設備補貼的政策,鼓勵了可近性和採用,從而塑造了區域市場前景。
The Global Homecare Oxygen Concentrators Market is expected to register 6% CAGR during 2023-2032, fueled by the rising prevalence of respiratory disorders, shift towards home based healthcare, and advancements in medical technologies.
According to a report published by NCD Alliance in 2022, globally, almost 550 million adults grapple with chronic respiratory diseases, and this number is consistently on the ascent. With an increasing number of individuals diagnosed with chronic respiratory conditions such as chronic obstructive pulmonary disease (COPD) and asthma, the demand for home-based oxygen therapy is on the rise.
Furthermore, as per the data published by Visual Capitalist, in 2022, the global population aged 65 years and above reached 771 million, constituting nearly 10% of the world's populace and it is projected to surge to 16% by the year 2050. As the global population ages, the susceptibility to lifestyle diseases as well as respiratory conditions increases, boosting the product adoption.
The homecare oxygen concentrators industry is classified based on product, technology, and region.
The fixed oxygen concentrators segment is expected to contribute substantially towards industry growth during the forecast period owing to innovations in terms of efficiency, noise reduction, and user-friendly features. The product not only ensures a continuous and reliable oxygen supply but also provides enhanced patient comfort and accessibility. Moreover, modern fixed oxygen concentrators are equipped with extended battery life which enhances the device's usability, allowing patients greater flexibility in their daily activities without the constraints of frequent recharging.
The pulse flow technology segment is expected to witness a steady growth through 2032 as it operates by delivering oxygen in pulses or bursts, aligning with the patient's breathing pattern. This innovative approach ensures oxygen is administered precisely when needed, conserving resources and enhancing the overall effectiveness of therapy. Moreover, the pulse flow devices are often designed to be more compact and lightweight compared to continuous flow devices, which ultimately enhances patient mobility, allowing individuals to engage in daily activities with greater ease.
Asia Pacific homecare oxygen concentrators industry is poised to experience robust growth during the study period driven by region's expansive population and evolving healthcare infrastructure. In countries like China and India, there is increasing focus on home-based healthcare solutions. This factor, along with policies supporting home-based healthcare solutions and subsidies for medical devices, have encouraged accessibility and adoption, thus shaping the regional market outlook.